Tachykinin peptides

Source: Wikipedia, the free encyclopedia.
Tachykinin family
SCOP2
1myu / SCOPe / SUPFAM
OPM superfamily143
OPM protein1myu
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

Tachykinin peptides are one of the largest families of

splice forms
that are made up of different sets of peptides.

Tachykinins

vasodilators
, and contract (directly or indirectly) many smooth muscles. Tachykinins are from ten to twelve residues long.

The two human tachykinin genes are called

N-terminally longer versions of neurokinin A that appear to be final peptide products in some tissues.[2]

TAC3 encodes neurokinin B.[8]

The best known tachykinin is Substance P.

Receptors

There are three known

inositol triphosphate. NK1, NK2 and NK3 selectively bind to substance P, neurokinin A, and neurokinin B
, respectively. Whilst the receptors are not specific to any individual tachykinin, they do have differing affinity for the tachykinins:

  • NK1: SP > NKA > NKB
  • NK2: NKA > NKB > SP
  • NK3: NKB > NKA > SP

Antagonists of neurokinin-1 (NK1) receptors (NK1 receptor antagonists), through which substance P acts, have been proposed to belong to a new class of antidepressants,[9]

antipsychotics.[13]
[14]

Tachykinin peptides are also involved in inflammation, and tachykinin receptor antagonists have been researched for use in treating inflammatory conditions such as asthma and irritable bowel syndrome.[15] [16] [17] The main use for which these antagonist drugs have been applied so far, however, is as antiemetics, in both human and veterinary medicine.[18] [19]

Examples of tachykinin antagonists include:[20]

Subfamilies

References

External links

This article incorporates text from the public domain Pfam and InterPro: IPR002040